相关实验视频

Updated: Jan 9, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

病例报告:急性泛性脱血性 pustulosis 与牛皮成功使用Secukinumab治疗

Ji-Na Zheng^1,2, Xinying Liu³, Yuling Shi^2,4

¹Department of Dermatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Frontiers in immunology

|December 5, 2025

概括

本案例研究报告了首次成功使用Secukinumab治疗重症斑块牛皮患者中甲醇诱导的急性泛性脱血性牛皮症 (AGEP). 这种生物疗法对这两种疾病都有好处.

科学领域:

皮肤病学皮肤病学
临床药理学临床药理学
免疫学免疫学免疫学

背景情况:

急性全身外血性瘤发病 (AGEP) 是一种严重的,罕见的皮肤药物反应,其特征是红血性皮肤突然出现无菌瘤.
甲米醇是AGEP的常见触发物,通常表现为发烧,胀和显著的皮肤炎症.
牛皮是一种慢性自身免疫性疾病,需要全身治疗,这可能会使像AGEP这样的重叠急性疾病的管理复杂化.

研究的目的:

报告第一个成功使用Secukinumab治疗重型斑块牛皮症患者中甲醇诱导的AGEP的病例.
突出生物治疗在治疗同时存在的皮肤病的潜在好处.
强调考虑生物药物对AGEP患者的重要性,特别是那些有牛皮病史的人.

主要方法:

一名56岁的男性患有严重的斑块性牛皮 (PASI分数为50.3) 在自行服用甲米醇后发展出AGEP.
临床证实了AGEP的诊断,实验室发现显示白细胞数量增加和C反应蛋白,以及肝功能异常.
该患者接受了300毫克的皮下Secukinumab治疗,随后对临床反应和牛皮区域和严重性指数 (PASI) 评分进行了监测.

主要成果:

在一周内,secukinumab治疗导致持续改善,PASI得分显著降至11.8,疹和红血病的消失.
患者在每月注射Secukinumab七个月后获得PASI 100反应,皮肤完全清除,没有复发.
这一案例证明了Secukinumab在同时治疗AGEP和严重斑块性牛皮的有效性.

结论:

在有严重斑块性牛皮病史的患者中,secukinumab是甲醇诱导的AGEP的有效治疗选择.
生物药物,如Secukinumab,应强烈考虑在AGEP的管理中,特别是在潜在的牛皮的患者中.
用单个生物药物向AGEP和牛皮可以提供显著的临床益处并改善患者的治疗结果.

关键词:

在 IL36RN 中.急性通用脱血性 pustulosis 的发生.案例报告案例报告状牛皮皮肤病干燥的干燥的干燥

更多相关视频

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

Accessory Structures of the Skin: Sebaceous Glands

Accessory Structures of the Skin: Sebaceous Glands

A sebaceous gland is a type of oil gland found almost all over the skin ( except palms and soles) and helps lubricate and waterproof the skin and hair. Most sebaceous glands are associated with hair follicles. They generate and excrete sebum, a mixture of lipids, onto the skin surface, thereby naturally lubricating the dry and dead layer of keratinized cells of the stratum corneum, keeping it pliable.
These glands that produce the oils on the skin and hair are holocrine glands. The mature...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...